Abstract
The prevalence of allergic bronchopulmonary aspergillosis (ABPA) in cystic fibrosis (CF) patients is difficult to determine because the data in the literature are not homogeneous or comparable. ABPA and CF have similar clinical symptoms which make diagnosis difficult and underestimate the real dimensions of the problem. We conducted an epidemiological study on 3089 Italian CF patients to determine the prevalence of ABPA in Italy and verify the percentage of positive tests in the employed diagnostic criteria. Our results indicate that the prevalence of ABPA in Italian CF patients is 6.18%, mainly in adolescents and young adults. ABPA is diagnosed using clinical symptoms (presence of episodic bronchial obstructions or typical radiographic features) and on the basis of other criteria which can only be partially fulfilled in paediatric patients. Among the diagnostic tests the most sensitive are the total IgE (84.5%), specific IgE anti-Aspergillus fumigatus (81.6%) and the prick test (68.3%). In the absence of clinical symptoms and gold standard diagnostic tests, serological positivity and/or the skin test are not sufficient evidence to confirm the presence of ABPA.
Similar content being viewed by others
References
Mroueh S, Spock A. Allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. Chest 1994; 105: 32–36.
Milla CE. Allergic bronchopulmonary aspergillosis and cystic fibrosis [editorial]. Pediatr Pulmonol 1999; 27: 71–73.
Hinson KFW, Moon AJ, Plummer NS. Bronchopulmonary aspergillosis-a review and a report of eight cases. Thorax 1952; 7: 317–333.
Becker JW, Burke W, McDonald G, Greenberg PA, Henderson WR, Aitken ML. Prevalence of allergic bronchopulmonary aspergillosis in adult patients with cystic fibrosis. Chest 1996; 109: 1536–1540.
Slavin RG. ABPA in CF: A devastating combination. Pediatr Pulmonol 1996; 21: 1–2.
Nelson LA, Callerame ML, Schwartz RH. Aspergillosis and atopy in cystic fibrosis. Am Rev Respir Dis 1979; 120: 863–873.
Laufer P, Fink JN, Bruns WT, et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis. J Allergy Clin Immunol 1984; 73: 44–48.
Valletta EA, Braggion C, Mastella G. Sensitization to Aspergillus and allergic bronchopulmonary aspergillosis in a cystic fibrosis population. Pediatric Asthma, Allergy & Immunology 1993; 7: 43–49.
Mastella G, Rainisio M, Harms HK, Hodson ME, Koch C, Navarro J. Is ABPA a serious complication? The European Epidemiology Registry of Cystic Fibrosis Workbook. 22nd European Cystic Fibrosis Conference. Berlin, June 18, 1998.
Rosenberg M, Patterson R, Mintzer R, Cooper BJ, Roberts M, Harris KE. Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis. Ann Intern Med 1977; 86: 405–414.
Patterson R, Greenberg PA, Radin RC, Roberts M. Allergic bronchopulmonary aspergillosis: Staging as an aid to management. Ann Intern Med 1982; 96: 286–291.
Hutcheson PS, Rejent AJ, Slavin RG. Variability in parameters of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. J Allergy Clin Immunol 1991; 88: 390–394.
Wang JLF, Patterson R, Rosenberg M, Roberts M, Cooper BJ. Serum IgE and IgG antibody activity against Aspergillus fumigatus as a diagnostic aid in allergic bronchopulmonary aspergillosis. Am Rev Respir Dis 1978; 117: 917–927.
Goodchild MC, Watson E. Diagnostic methods and screening. In: Hodson ME, Geddes D (eds), Cystic Fibrosis, London: Chapman & Hall, 1995; 179–211.
Mannes GPM. Clinical manifestations of Aspergillus fumigatus in children and adults with CF. Neth J Med 1999; 54 (Suppl): 11–12.
Wilmott RW, Kravitz RM. Allergic bronchopulmonary aspergillosis. In: Hilman BC (ed), Pediatric Respiratory Disease, Philadelphia: Saunders, 1993; 692–697.
Hiller EJ. Aspergillosis. J R Soc Med 1992; 85 (Suppl 19): 33–35.
Report of the Consensus Conference on Microbiology and Infectious Disease in Cystic Fibrosis. 17–19 May, 1994, Bethesda, MD.
Gondor M, Michaelst MG, Finder JD: Non-aspergius allergic bronchopulmonary mycosis in a pediatric patient with cystic fibrosis. Pediatrics 1998; 102: 1480–1482.
Cystic Fibrosis Foundation. Patient Registry 1997 Annual Data Report. Bethesda, MD, September 1998.
Padoan R, Marzano MT, Giunta A. Allergic bronchopulmonary aspergillosis in cystic fibrosis: 2 cases of ABPA in children under 5 years. Israel J Med Sci 1996; 32 (Suppl): S172.
Greenberg PA. Immunologic aspects of lung diseases and cystic fibrosis. JAMA 1997; 278: 1924–1930.
Hodson ME. Respiratory system-adults. In: Hodson ME, Geddes D (eds), Cystic Fibrosis, London: Chapman & Hall, 1995; 237–257.
McCarthy DS, Simon G, Hargreave FE. The radiological appearances in allergic bronchopulmonary aspergillosis. Clin Radiol 1970; 21: 366–375.
Hutcheson PS, Knutsen AP, Rejent A, Slavin R. A 12-year longitudinal study of Aspergillus fumigatus sensitivity in patients with cystic fibrosis. Chest 1996; 110: 363–366.
Wojnarowski Eichler I, Gartner C, Gotz M, Renner S, Koller DY, Frischer T. Sensitization to Aspergillus fumigatus and lung function in children with cystic fibrosis. Am J Respir Crit Care Med 1997; 155: 1902–1905.
Dreborg S, Frew A. Allergen standardization and skin tests. Allergy 1993; 14 (Suppl): 49–82.
Holland SM, Gallin JI. Disorders of granulocytes and monocytes. In: Fauci AS, Braunwald E, Isselbacher KJ, et al. (eds), Harrison's Principles of Internal Medicine, New York: McGraw-Hill, 1998; 351–359.
Schwartz RH, Johnstone D, Holsclaw DS, Dooley RR. Serum precipitins to Aspergillus fumigatus in cystic fibrosis patients. Am J Dis Child 1970; 120: 432–433.
Nikolaizik WH, Moser M, Cramery R, et al. Identification of allergic bronchopulmonary aspergillosis in cystic fibrosis patients by recombinant Aspergillus fumigatus I/a-specific serology. Am J Respir Crit Care Med 1995; 152: 634–639.
Taccetti G, Campana S. Microbiologic data overview of Italian cystic fibrosis patients. Eur J Epidemiol 1997; 13: 323–327.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Taccetti, G., Procopio, E., Marianelli, L. et al. Allergic bronchopulmonary aspergillosis in Italian cystic fibrosis patients: Prevalence and percentage of positive tests in the employed diagnostic criteria. Eur J Epidemiol 16, 837–842 (2000). https://doi.org/10.1023/A:1007670717619
Issue Date:
DOI: https://doi.org/10.1023/A:1007670717619